nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—lung cancer	0.15	0.359	CbGaD
Azelastine—CYP2E1—lung cancer	0.107	0.255	CbGaD
Azelastine—CYP1A1—lung cancer	0.105	0.252	CbGaD
Azelastine—ABCB1—lung cancer	0.0558	0.134	CbGaD
Azelastine—CYP1A1—Gefitinib—lung cancer	0.0259	0.0645	CbGbCtD
Azelastine—CYP3A5—Gefitinib—lung cancer	0.0155	0.0387	CbGbCtD
Azelastine—CYP1A1—Erlotinib—lung cancer	0.0153	0.0381	CbGbCtD
Azelastine—CYP3A5—Teniposide—lung cancer	0.0151	0.0375	CbGbCtD
Azelastine—CYP2C19—Gefitinib—lung cancer	0.0125	0.0312	CbGbCtD
Azelastine—CYP2C19—Teniposide—lung cancer	0.0121	0.0303	CbGbCtD
Azelastine—ABCB1—Topotecan—lung cancer	0.0111	0.0275	CbGbCtD
Azelastine—CYP2B6—Irinotecan—lung cancer	0.0105	0.0262	CbGbCtD
Azelastine—CYP2C9—Gefitinib—lung cancer	0.0104	0.026	CbGbCtD
Azelastine—ABCB1—Gefitinib—lung cancer	0.0101	0.0252	CbGbCtD
Azelastine—CYP2C9—Teniposide—lung cancer	0.0101	0.0252	CbGbCtD
Azelastine—CYP2D6—Gefitinib—lung cancer	0.00952	0.0237	CbGbCtD
Azelastine—CYP3A5—Crizotinib—lung cancer	0.00952	0.0237	CbGbCtD
Azelastine—CYP3A5—Erlotinib—lung cancer	0.00918	0.0229	CbGbCtD
Azelastine—CYP2C8—Erlotinib—lung cancer	0.00883	0.022	CbGbCtD
Azelastine—CYP2B6—Cisplatin—lung cancer	0.00858	0.0214	CbGbCtD
Azelastine—CYP2E1—Etoposide—lung cancer	0.00855	0.0213	CbGbCtD
Azelastine—CYP3A5—Paclitaxel—lung cancer	0.00841	0.0209	CbGbCtD
Azelastine—CYP3A5—Irinotecan—lung cancer	0.00829	0.0207	CbGbCtD
Azelastine—CYP2C8—Paclitaxel—lung cancer	0.00808	0.0201	CbGbCtD
Azelastine—ABCB1—Vinorelbine—lung cancer	0.00779	0.0194	CbGbCtD
Azelastine—CYP2D6—Vinorelbine—lung cancer	0.00734	0.0183	CbGbCtD
Azelastine—CYP1A2—Erlotinib—lung cancer	0.00683	0.017	CbGbCtD
Azelastine—CYP3A5—Etoposide—lung cancer	0.00664	0.0166	CbGbCtD
Azelastine—CYP3A4—Topotecan—lung cancer	0.00662	0.0165	CbGbCtD
Azelastine—CYP2C8—Etoposide—lung cancer	0.00639	0.0159	CbGbCtD
Azelastine—ABCB1—Crizotinib—lung cancer	0.0062	0.0154	CbGbCtD
Azelastine—CYP3A5—Docetaxel—lung cancer	0.00608	0.0151	CbGbCtD
Azelastine—CYP3A4—Gefitinib—lung cancer	0.00606	0.0151	CbGbCtD
Azelastine—ABCB1—Gemcitabine—lung cancer	0.00606	0.0151	CbGbCtD
Azelastine—ABCB1—Erlotinib—lung cancer	0.00598	0.0149	CbGbCtD
Azelastine—CYP3A4—Teniposide—lung cancer	0.00587	0.0146	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—lung cancer	0.00575	0.0143	CbGbCtD
Azelastine—CYP2C9—Paclitaxel—lung cancer	0.00564	0.014	CbGbCtD
Azelastine—CYP2D6—Erlotinib—lung cancer	0.00563	0.014	CbGbCtD
Azelastine—ABCB1—Paclitaxel—lung cancer	0.00547	0.0136	CbGbCtD
Azelastine—ABCB1—Irinotecan—lung cancer	0.0054	0.0134	CbGbCtD
Azelastine—CYP1A2—Etoposide—lung cancer	0.00494	0.0123	CbGbCtD
Azelastine—ABCB1—Vinblastine—lung cancer	0.0048	0.012	CbGbCtD
Azelastine—CYP3A4—Vinorelbine—lung cancer	0.00467	0.0116	CbGbCtD
Azelastine—CYP2C9—Cisplatin—lung cancer	0.00453	0.0113	CbGbCtD
Azelastine—CYP2D6—Vinblastine—lung cancer	0.00452	0.0113	CbGbCtD
Azelastine—ABCB1—Cisplatin—lung cancer	0.0044	0.011	CbGbCtD
Azelastine—ABCB1—Etoposide—lung cancer	0.00432	0.0108	CbGbCtD
Azelastine—ABCB1—Docetaxel—lung cancer	0.00396	0.00986	CbGbCtD
Azelastine—CYP3A4—Crizotinib—lung cancer	0.00371	0.00925	CbGbCtD
Azelastine—CYP3A4—Erlotinib—lung cancer	0.00358	0.00892	CbGbCtD
Azelastine—CYP3A4—Paclitaxel—lung cancer	0.00328	0.00817	CbGbCtD
Azelastine—CYP3A4—Irinotecan—lung cancer	0.00323	0.00806	CbGbCtD
Azelastine—ABCB1—Doxorubicin—lung cancer	0.00295	0.00735	CbGbCtD
Azelastine—CYP3A4—Vinblastine—lung cancer	0.00288	0.00716	CbGbCtD
Azelastine—ABCB1—Methotrexate—lung cancer	0.00286	0.00712	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—lung cancer	0.00278	0.00692	CbGbCtD
Azelastine—CYP3A4—Etoposide—lung cancer	0.00259	0.00645	CbGbCtD
Azelastine—CYP3A4—Docetaxel—lung cancer	0.00237	0.0059	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—lung cancer	0.00177	0.0044	CbGbCtD
Azelastine—Headache—Erlotinib—lung cancer	9.7e-05	0.000982	CcSEcCtD
Azelastine—Asthma—Methotrexate—lung cancer	9.68e-05	0.00098	CcSEcCtD
Azelastine—Paraesthesia—Gemcitabine—lung cancer	9.66e-05	0.000978	CcSEcCtD
Azelastine—Cough—Paclitaxel—lung cancer	9.63e-05	0.000975	CcSEcCtD
Azelastine—Asthenia—Vinorelbine—lung cancer	9.61e-05	0.000973	CcSEcCtD
Azelastine—Dyspnoea—Gemcitabine—lung cancer	9.59e-05	0.000971	CcSEcCtD
Azelastine—Chest pain—Etoposide—lung cancer	9.59e-05	0.00097	CcSEcCtD
Azelastine—Nausea—Vinblastine—lung cancer	9.57e-05	0.000969	CcSEcCtD
Azelastine—Somnolence—Gemcitabine—lung cancer	9.57e-05	0.000968	CcSEcCtD
Azelastine—Hypertension—Paclitaxel—lung cancer	9.53e-05	0.000965	CcSEcCtD
Azelastine—Fatigue—Irinotecan—lung cancer	9.52e-05	0.000964	CcSEcCtD
Azelastine—Pruritus—Vinorelbine—lung cancer	9.48e-05	0.000959	CcSEcCtD
Azelastine—Discomfort—Etoposide—lung cancer	9.47e-05	0.000958	CcSEcCtD
Azelastine—Pain—Irinotecan—lung cancer	9.45e-05	0.000956	CcSEcCtD
Azelastine—Constipation—Irinotecan—lung cancer	9.45e-05	0.000956	CcSEcCtD
Azelastine—Chest pain—Paclitaxel—lung cancer	9.4e-05	0.000951	CcSEcCtD
Azelastine—Myalgia—Paclitaxel—lung cancer	9.4e-05	0.000951	CcSEcCtD
Azelastine—Anxiety—Paclitaxel—lung cancer	9.37e-05	0.000948	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—lung cancer	9.36e-05	0.000947	CcSEcCtD
Azelastine—Nausea—Topotecan—lung cancer	9.3e-05	0.000941	CcSEcCtD
Azelastine—Discomfort—Paclitaxel—lung cancer	9.29e-05	0.00094	CcSEcCtD
Azelastine—Fatigue—Gemcitabine—lung cancer	9.28e-05	0.000939	CcSEcCtD
Azelastine—Confusional state—Etoposide—lung cancer	9.26e-05	0.000938	CcSEcCtD
Azelastine—Pain—Gemcitabine—lung cancer	9.2e-05	0.000931	CcSEcCtD
Azelastine—Constipation—Gemcitabine—lung cancer	9.2e-05	0.000931	CcSEcCtD
Azelastine—Nausea—Erlotinib—lung cancer	9.2e-05	0.000931	CcSEcCtD
Azelastine—Dry mouth—Paclitaxel—lung cancer	9.19e-05	0.00093	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—lung cancer	9.19e-05	0.00093	CcSEcCtD
Azelastine—Diarrhoea—Vinorelbine—lung cancer	9.16e-05	0.000928	CcSEcCtD
Azelastine—Dysgeusia—Docetaxel—lung cancer	9.16e-05	0.000927	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Cisplatin—lung cancer	9.14e-05	0.000925	CcSEcCtD
Azelastine—Infection—Etoposide—lung cancer	9.13e-05	0.000924	CcSEcCtD
Azelastine—Feeling abnormal—Irinotecan—lung cancer	9.1e-05	0.000921	CcSEcCtD
Azelastine—Confusional state—Paclitaxel—lung cancer	9.08e-05	0.000919	CcSEcCtD
Azelastine—Back pain—Docetaxel—lung cancer	9.05e-05	0.000916	CcSEcCtD
Azelastine—Gastrointestinal pain—Irinotecan—lung cancer	9.03e-05	0.000914	CcSEcCtD
Azelastine—Anaphylactic shock—Paclitaxel—lung cancer	9.01e-05	0.000912	CcSEcCtD
Azelastine—Paraesthesia—Cisplatin—lung cancer	9.01e-05	0.000912	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—lung cancer	9e-05	0.00091	CcSEcCtD
Azelastine—Tachycardia—Etoposide—lung cancer	8.97e-05	0.000908	CcSEcCtD
Azelastine—Infection—Paclitaxel—lung cancer	8.95e-05	0.000906	CcSEcCtD
Azelastine—Dyspnoea—Cisplatin—lung cancer	8.94e-05	0.000905	CcSEcCtD
Azelastine—Feeling abnormal—Gemcitabine—lung cancer	8.87e-05	0.000897	CcSEcCtD
Azelastine—Dizziness—Vinorelbine—lung cancer	8.86e-05	0.000896	CcSEcCtD
Azelastine—Tachycardia—Paclitaxel—lung cancer	8.79e-05	0.00089	CcSEcCtD
Azelastine—Abdominal pain—Irinotecan—lung cancer	8.73e-05	0.000884	CcSEcCtD
Azelastine—Body temperature increased—Irinotecan—lung cancer	8.73e-05	0.000884	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—lung cancer	8.67e-05	0.000878	CcSEcCtD
Azelastine—Pain—Cisplatin—lung cancer	8.58e-05	0.000868	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—lung cancer	8.55e-05	0.000866	CcSEcCtD
Azelastine—Vomiting—Vinorelbine—lung cancer	8.52e-05	0.000862	CcSEcCtD
Azelastine—Body temperature increased—Gemcitabine—lung cancer	8.51e-05	0.000861	CcSEcCtD
Azelastine—Rash—Vinorelbine—lung cancer	8.45e-05	0.000855	CcSEcCtD
Azelastine—Dermatitis—Vinorelbine—lung cancer	8.44e-05	0.000854	CcSEcCtD
Azelastine—Headache—Vinorelbine—lung cancer	8.39e-05	0.000849	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—lung cancer	8.39e-05	0.000849	CcSEcCtD
Azelastine—Asthma—Doxorubicin—lung cancer	8.38e-05	0.000848	CcSEcCtD
Azelastine—Palpitations—Docetaxel—lung cancer	8.27e-05	0.000837	CcSEcCtD
Azelastine—Feeling abnormal—Cisplatin—lung cancer	8.27e-05	0.000837	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—lung cancer	8.25e-05	0.000835	CcSEcCtD
Azelastine—Haematuria—Methotrexate—lung cancer	8.23e-05	0.000833	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.21e-05	0.000831	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—lung cancer	8.19e-05	0.000829	CcSEcCtD
Azelastine—Somnolence—Etoposide—lung cancer	8.17e-05	0.000827	CcSEcCtD
Azelastine—Cough—Docetaxel—lung cancer	8.16e-05	0.000826	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—lung cancer	8.14e-05	0.000824	CcSEcCtD
Azelastine—Hypersensitivity—Irinotecan—lung cancer	8.14e-05	0.000824	CcSEcCtD
Azelastine—Paraesthesia—Paclitaxel—lung cancer	8.09e-05	0.000819	CcSEcCtD
Azelastine—Hypertension—Docetaxel—lung cancer	8.08e-05	0.000818	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—lung cancer	8.06e-05	0.000816	CcSEcCtD
Azelastine—Dyspnoea—Paclitaxel—lung cancer	8.03e-05	0.000813	CcSEcCtD
Azelastine—Somnolence—Paclitaxel—lung cancer	8.01e-05	0.000811	CcSEcCtD
Azelastine—Chest pain—Docetaxel—lung cancer	7.97e-05	0.000806	CcSEcCtD
Azelastine—Myalgia—Docetaxel—lung cancer	7.97e-05	0.000806	CcSEcCtD
Azelastine—Nausea—Vinorelbine—lung cancer	7.96e-05	0.000805	CcSEcCtD
Azelastine—Body temperature increased—Cisplatin—lung cancer	7.93e-05	0.000802	CcSEcCtD
Azelastine—Asthenia—Irinotecan—lung cancer	7.93e-05	0.000802	CcSEcCtD
Azelastine—Fatigue—Etoposide—lung cancer	7.92e-05	0.000802	CcSEcCtD
Azelastine—Constipation—Etoposide—lung cancer	7.86e-05	0.000795	CcSEcCtD
Azelastine—Pain—Etoposide—lung cancer	7.86e-05	0.000795	CcSEcCtD
Azelastine—Dry mouth—Docetaxel—lung cancer	7.79e-05	0.000788	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—lung cancer	7.79e-05	0.000788	CcSEcCtD
Azelastine—Fatigue—Paclitaxel—lung cancer	7.77e-05	0.000786	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—lung cancer	7.74e-05	0.000784	CcSEcCtD
Azelastine—Asthenia—Gemcitabine—lung cancer	7.72e-05	0.000781	CcSEcCtD
Azelastine—Pain—Paclitaxel—lung cancer	7.7e-05	0.00078	CcSEcCtD
Azelastine—Constipation—Paclitaxel—lung cancer	7.7e-05	0.00078	CcSEcCtD
Azelastine—Confusional state—Docetaxel—lung cancer	7.7e-05	0.000779	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—lung cancer	7.69e-05	0.000778	CcSEcCtD
Azelastine—Anaphylactic shock—Docetaxel—lung cancer	7.64e-05	0.000773	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—lung cancer	7.63e-05	0.000772	CcSEcCtD
Azelastine—Pruritus—Gemcitabine—lung cancer	7.61e-05	0.000771	CcSEcCtD
Azelastine—Infection—Docetaxel—lung cancer	7.59e-05	0.000768	CcSEcCtD
Azelastine—Feeling abnormal—Etoposide—lung cancer	7.57e-05	0.000766	CcSEcCtD
Azelastine—Diarrhoea—Irinotecan—lung cancer	7.56e-05	0.000765	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—lung cancer	7.51e-05	0.00076	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—lung cancer	7.47e-05	0.000756	CcSEcCtD
Azelastine—Tachycardia—Docetaxel—lung cancer	7.45e-05	0.000754	CcSEcCtD
Azelastine—Feeling abnormal—Paclitaxel—lung cancer	7.42e-05	0.000751	CcSEcCtD
Azelastine—Hypersensitivity—Cisplatin—lung cancer	7.39e-05	0.000748	CcSEcCtD
Azelastine—Gastrointestinal pain—Paclitaxel—lung cancer	7.37e-05	0.000746	CcSEcCtD
Azelastine—Diarrhoea—Gemcitabine—lung cancer	7.36e-05	0.000745	CcSEcCtD
Azelastine—Dizziness—Irinotecan—lung cancer	7.3e-05	0.000739	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—lung cancer	7.26e-05	0.000735	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—lung cancer	7.26e-05	0.000735	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—lung cancer	7.26e-05	0.000735	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—lung cancer	7.24e-05	0.000733	CcSEcCtD
Azelastine—Asthenia—Cisplatin—lung cancer	7.2e-05	0.000728	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—lung cancer	7.12e-05	0.000721	CcSEcCtD
Azelastine—Body temperature increased—Paclitaxel—lung cancer	7.12e-05	0.000721	CcSEcCtD
Azelastine—Abdominal pain—Paclitaxel—lung cancer	7.12e-05	0.000721	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—lung cancer	7.05e-05	0.000713	CcSEcCtD
Azelastine—Vomiting—Irinotecan—lung cancer	7.02e-05	0.000711	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—lung cancer	7.01e-05	0.00071	CcSEcCtD
Azelastine—Rash—Irinotecan—lung cancer	6.97e-05	0.000705	CcSEcCtD
Azelastine—Dermatitis—Irinotecan—lung cancer	6.96e-05	0.000704	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Docetaxel—lung cancer	6.96e-05	0.000704	CcSEcCtD
Azelastine—Headache—Irinotecan—lung cancer	6.92e-05	0.0007	CcSEcCtD
Azelastine—Diarrhoea—Cisplatin—lung cancer	6.86e-05	0.000695	CcSEcCtD
Azelastine—Paraesthesia—Docetaxel—lung cancer	6.86e-05	0.000694	CcSEcCtD
Azelastine—Vomiting—Gemcitabine—lung cancer	6.84e-05	0.000692	CcSEcCtD
Azelastine—Dyspnoea—Docetaxel—lung cancer	6.81e-05	0.000689	CcSEcCtD
Azelastine—Somnolence—Docetaxel—lung cancer	6.79e-05	0.000687	CcSEcCtD
Azelastine—Rash—Gemcitabine—lung cancer	6.78e-05	0.000687	CcSEcCtD
Azelastine—Dermatitis—Gemcitabine—lung cancer	6.78e-05	0.000686	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—lung cancer	6.77e-05	0.000685	CcSEcCtD
Azelastine—Headache—Gemcitabine—lung cancer	6.74e-05	0.000682	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—lung cancer	6.72e-05	0.000681	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—lung cancer	6.67e-05	0.000676	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—lung cancer	6.66e-05	0.000674	CcSEcCtD
Azelastine—Hypersensitivity—Paclitaxel—lung cancer	6.64e-05	0.000672	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—lung cancer	6.6e-05	0.000668	CcSEcCtD
Azelastine—Asthenia—Etoposide—lung cancer	6.59e-05	0.000667	CcSEcCtD
Azelastine—Fatigue—Docetaxel—lung cancer	6.58e-05	0.000666	CcSEcCtD
Azelastine—Nausea—Irinotecan—lung cancer	6.56e-05	0.000664	CcSEcCtD
Azelastine—Pain—Docetaxel—lung cancer	6.53e-05	0.000661	CcSEcCtD
Azelastine—Constipation—Docetaxel—lung cancer	6.53e-05	0.000661	CcSEcCtD
Azelastine—Back pain—Methotrexate—lung cancer	6.52e-05	0.00066	CcSEcCtD
Azelastine—Pruritus—Etoposide—lung cancer	6.5e-05	0.000658	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—lung cancer	6.46e-05	0.000654	CcSEcCtD
Azelastine—Asthenia—Paclitaxel—lung cancer	6.46e-05	0.000654	CcSEcCtD
Azelastine—Nausea—Gemcitabine—lung cancer	6.39e-05	0.000647	CcSEcCtD
Azelastine—Vomiting—Cisplatin—lung cancer	6.38e-05	0.000645	CcSEcCtD
Azelastine—Pruritus—Paclitaxel—lung cancer	6.37e-05	0.000645	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—lung cancer	6.36e-05	0.000643	CcSEcCtD
Azelastine—Rash—Cisplatin—lung cancer	6.32e-05	0.00064	CcSEcCtD
Azelastine—Dermatitis—Cisplatin—lung cancer	6.32e-05	0.000639	CcSEcCtD
Azelastine—Feeling abnormal—Docetaxel—lung cancer	6.29e-05	0.000637	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—lung cancer	6.29e-05	0.000636	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—lung cancer	6.27e-05	0.000634	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—lung cancer	6.26e-05	0.000633	CcSEcCtD
Azelastine—Gastrointestinal pain—Docetaxel—lung cancer	6.24e-05	0.000632	CcSEcCtD
Azelastine—Flushing—Doxorubicin—lung cancer	6.23e-05	0.00063	CcSEcCtD
Azelastine—Diarrhoea—Paclitaxel—lung cancer	6.16e-05	0.000624	CcSEcCtD
Azelastine—Malaise—Methotrexate—lung cancer	6.08e-05	0.000615	CcSEcCtD
Azelastine—Dizziness—Etoposide—lung cancer	6.08e-05	0.000615	CcSEcCtD
Azelastine—Vertigo—Methotrexate—lung cancer	6.06e-05	0.000613	CcSEcCtD
Azelastine—Abdominal pain—Docetaxel—lung cancer	6.04e-05	0.000611	CcSEcCtD
Azelastine—Body temperature increased—Docetaxel—lung cancer	6.04e-05	0.000611	CcSEcCtD
Azelastine—Dizziness—Paclitaxel—lung cancer	5.96e-05	0.000603	CcSEcCtD
Azelastine—Nausea—Cisplatin—lung cancer	5.96e-05	0.000603	CcSEcCtD
Azelastine—Cough—Methotrexate—lung cancer	5.88e-05	0.000596	CcSEcCtD
Azelastine—Vomiting—Etoposide—lung cancer	5.84e-05	0.000591	CcSEcCtD
Azelastine—Rash—Etoposide—lung cancer	5.79e-05	0.000586	CcSEcCtD
Azelastine—Dermatitis—Etoposide—lung cancer	5.79e-05	0.000586	CcSEcCtD
Azelastine—Headache—Etoposide—lung cancer	5.76e-05	0.000583	CcSEcCtD
Azelastine—Myalgia—Methotrexate—lung cancer	5.74e-05	0.000581	CcSEcCtD
Azelastine—Chest pain—Methotrexate—lung cancer	5.74e-05	0.000581	CcSEcCtD
Azelastine—Tension—Doxorubicin—lung cancer	5.73e-05	0.00058	CcSEcCtD
Azelastine—Vomiting—Paclitaxel—lung cancer	5.73e-05	0.00058	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—lung cancer	5.72e-05	0.000579	CcSEcCtD
Azelastine—Rash—Paclitaxel—lung cancer	5.68e-05	0.000575	CcSEcCtD
Azelastine—Dermatitis—Paclitaxel—lung cancer	5.68e-05	0.000574	CcSEcCtD
Azelastine—Discomfort—Methotrexate—lung cancer	5.67e-05	0.000574	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—lung cancer	5.67e-05	0.000574	CcSEcCtD
Azelastine—Back pain—Doxorubicin—lung cancer	5.65e-05	0.000572	CcSEcCtD
Azelastine—Headache—Paclitaxel—lung cancer	5.64e-05	0.000571	CcSEcCtD
Azelastine—Hypersensitivity—Docetaxel—lung cancer	5.63e-05	0.000569	CcSEcCtD
Azelastine—Confusional state—Methotrexate—lung cancer	5.55e-05	0.000562	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—lung cancer	5.5e-05	0.000557	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—lung cancer	5.5e-05	0.000557	CcSEcCtD
Azelastine—Asthenia—Docetaxel—lung cancer	5.48e-05	0.000555	CcSEcCtD
Azelastine—Infection—Methotrexate—lung cancer	5.47e-05	0.000553	CcSEcCtD
Azelastine—Nausea—Etoposide—lung cancer	5.46e-05	0.000552	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—lung cancer	5.42e-05	0.000548	CcSEcCtD
Azelastine—Pruritus—Docetaxel—lung cancer	5.4e-05	0.000547	CcSEcCtD
Azelastine—Agitation—Doxorubicin—lung cancer	5.37e-05	0.000543	CcSEcCtD
Azelastine—Nausea—Paclitaxel—lung cancer	5.35e-05	0.000542	CcSEcCtD
Azelastine—Malaise—Doxorubicin—lung cancer	5.27e-05	0.000533	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—lung cancer	5.25e-05	0.000531	CcSEcCtD
Azelastine—Diarrhoea—Docetaxel—lung cancer	5.22e-05	0.000529	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—lung cancer	5.16e-05	0.000522	CcSEcCtD
Azelastine—Cough—Doxorubicin—lung cancer	5.1e-05	0.000516	CcSEcCtD
Azelastine—Dizziness—Docetaxel—lung cancer	5.05e-05	0.000511	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—lung cancer	5.04e-05	0.00051	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—lung cancer	5.01e-05	0.000508	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—lung cancer	4.97e-05	0.000503	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—lung cancer	4.97e-05	0.000503	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—lung cancer	4.95e-05	0.000501	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—lung cancer	4.94e-05	0.0005	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—lung cancer	4.91e-05	0.000497	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—lung cancer	4.91e-05	0.000497	CcSEcCtD
Azelastine—Somnolence—Methotrexate—lung cancer	4.89e-05	0.000495	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—lung cancer	4.86e-05	0.000492	CcSEcCtD
Azelastine—Vomiting—Docetaxel—lung cancer	4.86e-05	0.000491	CcSEcCtD
Azelastine—Rash—Docetaxel—lung cancer	4.81e-05	0.000487	CcSEcCtD
Azelastine—Dermatitis—Docetaxel—lung cancer	4.81e-05	0.000487	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—lung cancer	4.81e-05	0.000486	CcSEcCtD
Azelastine—Headache—Docetaxel—lung cancer	4.78e-05	0.000484	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—lung cancer	4.77e-05	0.000482	CcSEcCtD
Azelastine—Fatigue—Methotrexate—lung cancer	4.75e-05	0.00048	CcSEcCtD
Azelastine—Infection—Doxorubicin—lung cancer	4.73e-05	0.000479	CcSEcCtD
Azelastine—Pain—Methotrexate—lung cancer	4.71e-05	0.000476	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—lung cancer	4.65e-05	0.000471	CcSEcCtD
Azelastine—Nausea—Docetaxel—lung cancer	4.54e-05	0.000459	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—lung cancer	4.54e-05	0.000459	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—lung cancer	4.5e-05	0.000456	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—lung cancer	4.35e-05	0.00044	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—lung cancer	4.35e-05	0.00044	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.34e-05	0.000439	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—lung cancer	4.28e-05	0.000433	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—lung cancer	4.25e-05	0.00043	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—lung cancer	4.24e-05	0.000429	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—lung cancer	4.11e-05	0.000416	CcSEcCtD
Azelastine—Pain—Doxorubicin—lung cancer	4.08e-05	0.000412	CcSEcCtD
Azelastine—Constipation—Doxorubicin—lung cancer	4.08e-05	0.000412	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—lung cancer	4.05e-05	0.00041	CcSEcCtD
Azelastine—Asthenia—Methotrexate—lung cancer	3.95e-05	0.0004	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—lung cancer	3.93e-05	0.000397	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—lung cancer	3.9e-05	0.000394	CcSEcCtD
Azelastine—Pruritus—Methotrexate—lung cancer	3.89e-05	0.000394	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—lung cancer	3.77e-05	0.000381	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—lung cancer	3.77e-05	0.000381	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—lung cancer	3.77e-05	0.000381	CcSEcCtD
Azelastine—Dizziness—Methotrexate—lung cancer	3.64e-05	0.000368	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—lung cancer	3.51e-05	0.000355	CcSEcCtD
Azelastine—Vomiting—Methotrexate—lung cancer	3.5e-05	0.000354	CcSEcCtD
Azelastine—Rash—Methotrexate—lung cancer	3.47e-05	0.000351	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—lung cancer	3.47e-05	0.000351	CcSEcCtD
Azelastine—Headache—Methotrexate—lung cancer	3.45e-05	0.000349	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—lung cancer	3.42e-05	0.000346	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—lung cancer	3.37e-05	0.000341	CcSEcCtD
Azelastine—Nausea—Methotrexate—lung cancer	3.27e-05	0.000331	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—lung cancer	3.26e-05	0.00033	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—lung cancer	3.15e-05	0.000319	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—lung cancer	3.03e-05	0.000307	CcSEcCtD
Azelastine—Rash—Doxorubicin—lung cancer	3e-05	0.000304	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—lung cancer	3e-05	0.000304	CcSEcCtD
Azelastine—Headache—Doxorubicin—lung cancer	2.99e-05	0.000302	CcSEcCtD
Azelastine—Nausea—Doxorubicin—lung cancer	2.83e-05	0.000287	CcSEcCtD
Azelastine—CYP2D6—Metabolism—ABCB1—lung cancer	2.81e-06	3.41e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTT1—lung cancer	2.8e-06	3.4e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ERCC2—lung cancer	2.79e-06	3.39e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	2.79e-06	3.38e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ABCB1—lung cancer	2.79e-06	3.38e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—lung cancer	2.78e-06	3.37e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CB—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2A6—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GCLC—lung cancer	2.77e-06	3.36e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TYMS—lung cancer	2.76e-06	3.35e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP1A1—lung cancer	2.75e-06	3.33e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—lung cancer	2.74e-06	3.33e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	2.74e-06	3.33e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TYMS—lung cancer	2.74e-06	3.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—MAPK3—lung cancer	2.73e-06	3.31e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—lung cancer	2.73e-06	3.31e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ERCC2—lung cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—STK11—lung cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—lung cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—lung cancer	2.72e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—lung cancer	2.71e-06	3.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	2.71e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—lung cancer	2.71e-06	3.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOA1—lung cancer	2.7e-06	3.28e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CREBBP—lung cancer	2.7e-06	3.28e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CG—lung cancer	2.69e-06	3.27e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BRAF—lung cancer	2.68e-06	3.25e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6R—lung cancer	2.65e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CREBBP—lung cancer	2.65e-06	3.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CREBBP—lung cancer	2.64e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CREBBP—lung cancer	2.64e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO1—lung cancer	2.63e-06	3.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—lung cancer	2.6e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.59e-06	3.14e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.59e-06	3.14e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ERCC2—lung cancer	2.57e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A1—lung cancer	2.57e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CD—lung cancer	2.56e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—lung cancer	2.56e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.55e-06	3.1e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ERCC2—lung cancer	2.54e-06	3.09e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—lung cancer	2.53e-06	3.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAP2K1—lung cancer	2.52e-06	3.06e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—lung cancer	2.52e-06	3.05e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CD—lung cancer	2.51e-06	3.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CD—lung cancer	2.51e-06	3.04e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CD—lung cancer	2.51e-06	3.04e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CREBBP—lung cancer	2.5e-06	3.03e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	2.49e-06	3.02e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MDM2—lung cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—lung cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—lung cancer	2.47e-06	3e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RAF1—lung cancer	2.47e-06	3e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CG—lung cancer	2.47e-06	3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—KRAS—lung cancer	2.46e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAT—lung cancer	2.45e-06	2.97e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	2.45e-06	2.97e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.43e-06	2.95e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MTOR—lung cancer	2.41e-06	2.93e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	2.41e-06	2.93e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOA1—lung cancer	2.41e-06	2.93e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTEN—lung cancer	2.39e-06	2.9e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCB1—lung cancer	2.38e-06	2.89e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CD—lung cancer	2.37e-06	2.87e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOA1—lung cancer	2.36e-06	2.86e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.35e-06	2.86e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—lung cancer	2.35e-06	2.85e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TYMS—lung cancer	2.34e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—lung cancer	2.34e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NQO1—lung cancer	2.33e-06	2.83e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	2.32e-06	2.82e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—lung cancer	2.31e-06	2.81e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.31e-06	2.8e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	2.31e-06	2.8e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CREBBP—lung cancer	2.29e-06	2.78e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—EP300—lung cancer	2.28e-06	2.77e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	2.26e-06	2.74e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MDM2—lung cancer	2.25e-06	2.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	2.24e-06	2.72e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RAF1—lung cancer	2.24e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CB—lung cancer	2.23e-06	2.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—lung cancer	2.22e-06	2.69e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOA1—lung cancer	2.22e-06	2.69e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—lung cancer	2.22e-06	2.69e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—lung cancer	2.21e-06	2.69e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—lung cancer	2.21e-06	2.69e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—lung cancer	2.21e-06	2.68e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CG—lung cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOA1—lung cancer	2.2e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.19e-06	2.66e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CB—lung cancer	2.19e-06	2.66e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CB—lung cancer	2.19e-06	2.65e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MTOR—lung cancer	2.19e-06	2.65e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CB—lung cancer	2.18e-06	2.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ERCC2—lung cancer	2.17e-06	2.64e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CD—lung cancer	2.17e-06	2.63e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—lung cancer	2.17e-06	2.63e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—lung cancer	2.16e-06	2.63e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—lung cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—JUN—lung cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CG—lung cancer	2.15e-06	2.61e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—lung cancer	2.14e-06	2.6e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.11e-06	2.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—lung cancer	2.1e-06	2.55e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—lung cancer	2.1e-06	2.55e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—STK11—lung cancer	2.1e-06	2.55e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—lung cancer	2.1e-06	2.55e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	2.09e-06	2.54e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRAS—lung cancer	2.09e-06	2.53e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTEN—lung cancer	2.09e-06	2.53e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CB—lung cancer	2.06e-06	2.5e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—lung cancer	2.05e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—lung cancer	2.04e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CREBBP—lung cancer	2.04e-06	2.48e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	2.04e-06	2.47e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—lung cancer	2.03e-06	2.46e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.03e-06	2.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CG—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—lung cancer	2.01e-06	2.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—lung cancer	2e-06	2.42e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CREBBP—lung cancer	1.99e-06	2.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EP300—lung cancer	1.99e-06	2.41e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—lung cancer	1.96e-06	2.37e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—JUN—lung cancer	1.95e-06	2.37e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—lung cancer	1.94e-06	2.36e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CD—lung cancer	1.94e-06	2.35e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SRC—lung cancer	1.94e-06	2.35e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTEN—lung cancer	1.93e-06	2.34e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—lung cancer	1.93e-06	2.34e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—lung cancer	1.91e-06	2.32e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—lung cancer	1.91e-06	2.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—lung cancer	1.9e-06	2.31e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.89e-06	2.3e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CB—lung cancer	1.89e-06	2.3e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTEN—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CD—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAT—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTEN—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTEN—lung cancer	1.89e-06	2.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.88e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOA1—lung cancer	1.88e-06	2.28e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CREBBP—lung cancer	1.88e-06	2.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—lung cancer	1.87e-06	2.27e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—lung cancer	1.87e-06	2.26e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.87e-06	2.26e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CREBBP—lung cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—EP300—lung cancer	1.84e-06	2.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCB1—lung cancer	1.84e-06	2.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TYMS—lung cancer	1.81e-06	2.19e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—EP300—lung cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EP300—lung cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.8e-06	2.19e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—EP300—lung cancer	1.8e-06	2.18e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—lung cancer	1.78e-06	2.17e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTEN—lung cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.78e-06	2.16e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CD—lung cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—lung cancer	1.76e-06	2.13e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SRC—lung cancer	1.75e-06	2.13e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—lung cancer	1.74e-06	2.12e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.73e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.72e-06	2.08e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.71e-06	2.07e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—EP300—lung cancer	1.7e-06	2.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.7e-06	2.06e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—lung cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—lung cancer	1.69e-06	2.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NRAS—lung cancer	1.69e-06	2.04e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ERCC2—lung cancer	1.68e-06	2.04e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—lung cancer	1.67e-06	2.03e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CB—lung cancer	1.65e-06	2e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTEN—lung cancer	1.63e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—lung cancer	1.63e-06	1.98e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—lung cancer	1.63e-06	1.98e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.61e-06	1.96e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.6e-06	1.94e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CREBBP—lung cancer	1.59e-06	1.93e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—lung cancer	1.57e-06	1.9e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—EP300—lung cancer	1.56e-06	1.89e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.55e-06	1.88e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.54e-06	1.87e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—lung cancer	1.54e-06	1.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—lung cancer	1.54e-06	1.86e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—lung cancer	1.53e-06	1.85e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.51e-06	1.83e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—lung cancer	1.49e-06	1.81e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	1.79e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTEN—lung cancer	1.46e-06	1.77e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOA1—lung cancer	1.45e-06	1.76e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KRAS—lung cancer	1.45e-06	1.76e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTEN—lung cancer	1.42e-06	1.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.42e-06	1.73e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—EP300—lung cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—lung cancer	1.38e-06	1.67e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—lung cancer	1.36e-06	1.65e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.36e-06	1.65e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—EP300—lung cancer	1.36e-06	1.65e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTEN—lung cancer	1.34e-06	1.63e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—lung cancer	1.33e-06	1.62e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.33e-06	1.62e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—lung cancer	1.33e-06	1.62e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTEN—lung cancer	1.33e-06	1.61e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.33e-06	1.61e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.32e-06	1.6e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—lung cancer	1.3e-06	1.58e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.3e-06	1.58e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—lung cancer	1.29e-06	1.56e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—EP300—lung cancer	1.28e-06	1.55e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—EP300—lung cancer	1.27e-06	1.54e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—lung cancer	1.26e-06	1.53e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—lung cancer	1.26e-06	1.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRAS—lung cancer	1.23e-06	1.5e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CREBBP—lung cancer	1.23e-06	1.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.2e-06	1.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—lung cancer	1.18e-06	1.43e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.16e-06	1.41e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—lung cancer	1.15e-06	1.4e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—lung cancer	1.15e-06	1.4e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTEN—lung cancer	1.14e-06	1.38e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—lung cancer	1.11e-06	1.35e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—lung cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—lung cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—lung cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—EP300—lung cancer	1.08e-06	1.32e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.03e-06	1.25e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—lung cancer	1.03e-06	1.25e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.02e-06	1.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—lung cancer	1.01e-06	1.22e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—lung cancer	1e-06	1.22e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—lung cancer	9.47e-07	1.15e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—lung cancer	9.42e-07	1.14e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—lung cancer	9.39e-07	1.14e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTEN—lung cancer	8.77e-07	1.06e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—lung cancer	8.41e-07	1.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—EP300—lung cancer	8.37e-07	1.02e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—lung cancer	8.21e-07	9.96e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—lung cancer	8.02e-07	9.73e-06	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—lung cancer	7.73e-07	9.38e-06	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—lung cancer	7.67e-07	9.3e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—lung cancer	6.55e-07	7.95e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—lung cancer	6.19e-07	7.51e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—lung cancer	5.06e-07	6.14e-06	CbGpPWpGaD
